Aroa Biosurgery Limited (ARX.AX)
AUD 0.39
(2.67%)
AUD 0.39
(2.67%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -7.36 Million AUD | -310.36% |
| 2023 | 3.49 Million AUD | 179.6% |
| 2022 | -3.74 Million AUD | 69.46% |
| 2021 | -14.55 Million AUD | -5973.85% |
| 2020 | -219.49 Thousand AUD | -112.56% |
| 2019 | 1.74 Million AUD | 212.2% |
| 2018 | -1.55 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | -327.12% |
| 2024 Q2 | -4.18 Million AUD | -125.45% |
| 2024 Q1 | -1.85 Million AUD | -123.71% |
| 2024 Q3 | -1.51 Million AUD | 63.78% |
| 2024 Q4 | -1.49 Million AUD | 1.09% |
| 2023 Q4 | -830.05 Thousand AUD | -408.51% |
| 2023 FY | - AUD | 179.6% |
| 2023 Q3 | -163.23 Thousand AUD | -240.32% |
| 2023 Q2 | 116.32 Thousand AUD | 0.0% |
| 2022 FY | - AUD | 69.46% |
| 2022 Q4 | -2.86 Million AUD | 0.0% |
| 2022 Q2 | -2.39 Million AUD | 0.0% |
| 2021 FY | - AUD | -5973.85% |
| 2021 Q4 | -3.54 Million AUD | 0.0% |
| 2021 Q2 | -3.9 Million AUD | 0.0% |
| 2020 Q2 | 1.58 Million AUD | 0.0% |
| 2020 Q4 | -1.81 Million AUD | 0.0% |
| 2020 FY | - AUD | -112.56% |
| 2019 FY | - AUD | 212.2% |
| 2018 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 79.593% |
| Adherium Limited | -11.56 Million AUD | 36.356% |
| Atomo Diagnostics Limited | -5.42 Million AUD | -35.707% |
| Anteris Technologies Ltd | -66.9 Million AUD | 88.999% |
| Control Bionics Limited | -5.15 Million AUD | -42.687% |
| CardieX Limited | -6.71 Million AUD | -9.658% |
| Compumedics Limited | 2.78 Million AUD | 363.897% |
| Cochlear Limited | 579.5 Million AUD | 101.27% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -110.782% |
| Cyclopharm Limited | -3.03 Million AUD | -142.515% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -251.954% |
| Nova Eye Medical Limited | -5.97 Million AUD | -23.099% |
| HeraMED Limited | -3.97 Million AUD | -85.296% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 66.347% |
| ImpediMed Limited | -22.05 Million AUD | 66.622% |
| InhaleRx Limited | -1.41 Million AUD | -420.609% |
| LBT Innovations Limited | -4.04 Million AUD | -81.775% |
| Micro-X Limited | -14.35 Million AUD | 48.714% |
| Neurotech International Limited | -8.24 Million AUD | 10.722% |
| OncoSil Medical Limited | -11.97 Million AUD | 38.544% |
| PolyNovo Limited | 5.17 Million AUD | 242.361% |
| Respiri Limited | -7.04 Million AUD | -4.4% |
| SomnoMed Limited | -2.32 Million AUD | -216.071% |
| Universal Biosensors, Inc. | -9.09 Million AUD | 19.035% |
| Uscom Limited | -1.5 Million AUD | -387.645% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | -49.674% |